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1. Introduction 
The gastrointestinal tract, home to a large flora of commensal bacteria, performs the 
essential role of degradation and absorption of food via gastrointestinal epithelia. The semi-
permeability of the epithelial barrier allows for food-derived nutrients to pass through and 
enter the bloodstream, while simultaneously acting as a physical and chemical barricade 
towards microbes. Despite this, many bacteria have evolved the means to elude the 
gastrointestinal tract and migrate to underlying host tissue, causing disease. These disease- 
causing bacteria are largely thought to obtain their virulence through horizontal gene 
transfer, which has enabled the bacterium to overcome the epithelial barrier and disguise 
itself from the intestinal immune system (Flannagan et al., 2009).  
Salmonella species are facultative, gram-negative intracellular bacteria harbouring over 2000 
serovars; however, only a handful is associated with disease in humans. While Salmonella 
remains the leading cause of bacterial gastroenteritis, it is also one the most extensively 
studied and well characterised bacterial species. Worldwide, Salmonella is thought to cause 
~1.3 billion cases of human disease, including diarrhoea and typhoid fever (McGhie et al., 
2009). Moreover, 3-5% of patients with typhoid fever develop persistent infection of the 
gallbladder which acts as a crucial reservoir to the human-specific Salmonella enteric serotype 
typhi (S. Typhi). The recent development of the streptomycin pre-treated murine model of 
Salmonella enterica serovar typhimurium (S. Typhimurium) has become the pinnacle in 
gaining critical insight into the pathogenesis of diseases caused by Salmonella. More 
specifically, it has enabled scientists to investigate molecular mechanisms of invasion, 
evasion, intracellular survival and persistence of Salmonella in host tissue.  
In this chapter, we aim to decipher the pathogenesis of Salmonella by breaking down and 
exploring the effects of various virulence factors in Salmonella. The knowledge of the 
molecular basis of host-pathogen interactions will bring help bridge the gap between 
molecular events and clinical presentations of Salmonellosis. 
2. Internalization of Salmonella 
2.1 M cells 
Membraneous epithelilal (M) cells are sparsely distributed, specialized cells characterized 
by an irregular microvilli apical surface and a basolateral cytoplasmic invagination (or an 
intraepithelial pocket) which can harbour lymphocytes or macrophages. M cells are not 
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randomly distributed; rather they reside in the specialised follicle-associated epithelium 
(FAE) overlying lymphoid aggregates such as Peyer’s patches. The molecular features of the 
apical surface of M cells promote adherence, uptake and sampling of inert particles and 
microbes within the lumen, which are transferred to the underlying lymphoid tissue where 
immunological responses are initiated (Kraehenbuhl & Neutra, 2000). In most cases, only 
antigens that adhere to the surface of M cells induce strong immunological responses. 
However, several types of bacteria and viruses are known to exploit M cells by selectively 
adhering to the apical surface, internalising themselves and evading mucosal immune 
responses (Neutra et al., 1996; Sansonetti & Phalipon, 1999). Numerous studies have shown 
both S. Typhi (Kohbata et al., 1986; Pascopella et al., 1995) and S. Typhimurium (Clark et al., 
1994; Jones et al., 1994) preferentially target and invade mouse M cells and that S. 
Typhimurium also invades M cells in calf ileal loops (Frost et al., 1997). Despite these 
reports, there is a lack of direct evidence that human M cells are a major site of Salmonella 
invasion, although it is widely speculated that sites of Salmonella evasion in humans parallel 
mice and calf studies. Supporting this is the presence of ulcerations corresponding to the 
position of Peyer’s patches in human typhoid (Owen, 1994).  
Studies of S. Typhimurium invasion in murine and calf M cells have revealed active 
processes of internalization. Membrane ruffles are a crucial determinate of salmonella 
invasion, as demonstrated in cultured epithelial cell lines (Galan & Collmer, 1999). The 
membrane ‘ruffler’ formation results from extensive rearrangement of M cell apical 
membranes due to the redistribution of polymerised actin to form membrane protrusions 
(Clark et al., 1994; Frost et al., 1997; Jones et al., 1994). This process is triggered by a active 
process in which the ultimate result is engulfment of Salmonella. It should be noted that not 
all bacterial uptake by M cells involves specialised adaptive processes. Some of the bacteria 
entry, such as in the case of Salmonella, is performed in a passive fashion by taking 
advantage of the M cell sampling and uptaking abilities. Although M cells appear to play a 
major role in salmonella internalization and evasion, this highly adaptive pathogen is able to 
exploit other routes that all amount to the pathogenesis of Salmonella.  
2.2 Macrophages 
Professional antigen presenting cells, such as macrophages are endlessly sampling luminal 
contents, phagocytising potential pathogens and presenting antigens to adaptive immune 
cells, in a process of maintaining host protection against potentially harmful microbes. 
Phagocytic uptake of gram-negative bacteria (such as Salmonella) is a complex mechanism 
which involves various receptors and interactions. Of particular importance are Pattern-
recognition receptors that recognise pathogen-associated molecular patterns that include 
lipopolysaccharides and flagellin. Macrophages are thought to readily recognise and engulf 
Salmonella in a independent fashion, thus offering an alternative independent point of entry.  
2.3 Enterocytes  
Enterocytes are simple columnar epithelial cells found in the intestine which offer the first 
line of defence against microbes in the lumen. Despite employing a vast array of protective 
features, many microbes including Salmonella have evolved strategies to secure their 
survival in host cells by manipulating cellular structures, as observed in M cells. Therefore, 
Salmonella also invades enterocytes by employing membrane ruffles.  
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2.4 Dendritic cells (DC) 
DCs are a heterogeneous group of cells that are categorized primarily by their resident 
tissue. They are best known for their ability to capture and present antigens and have been 
heavily implicated in host immune responses and self-tolerance. Salmonella appears to 
possess the ability to cross the gut epithelial via DCs. It has been proposed that Salmonella 
from the intestinal lumen is absorbed via dendritic projections that pass between adjacent 
intestinal epithelial cells without disturbing the epithelial barrier integrity (Rescigno et al., 
2001). This is through the utilization of fimbriae which selectively adheres Salmonella to 
dendritic projections, allowing Salmonella to invade DCs, thereby utilizing DCs as an 
additional entry point, as demonstrated in a recent study (Guo et al., 2007). 
3. Virulence genes  
The presence of virulence determinants in S. Typhimurium, and the somewhat related 
pathogenic E.coli, are thought to be acquired by lateral gene transfer (Boyd & Brussow, 2002; 
Schmidt & Hensel, 2004). Pathogenicity islands (PAI) describe chromosomal regions that 
contain virulence genes which are otherwise absent in non-pathogenic or closely related 
strains species (Hacker et al., 1990; Lavigne & Blanc-Potard, 2008). They are typically 
inserted adjacent to tRNA genes and their overall base composition differs markedly from 
the native bacterial chromosome, thereby implying they are acquired from a foreign source 
(Daigle, 2008). According to Schmidt and Hensel, 2004., five major PAI’s have been 
identified in S. Typhimurium, which are referred to as Salmonella pathogenicity islands (SPI) 
(Schmidt & Hensel, 2004). The human-specific S. Typhi contains a chromosomal region of 
virulence, SPI-7, not present in S. Typhimurium which causes unique clinical presentations 
in patients affected, such as typhoid fever.  
3.1 SPI-1 
T3SS-1, encoded by SPI-1, is required for SPI-1-dependant internalisation of non-pathogenic 
cells, such as M cells and epithelial cells, and mediates the translocation of effector proteins 
into eukaryotic cells (Ehrbar et al., 2002; Lostroh & Lee, 2001; Mills et al., 1995). At least 15 
effectors can be translocated by T3SS-1, most of which are encoded on the SPI-1, such as 
SptP, SipA, SipB and AvrA (McGhie et al., 2009). Until recently, T3SS-1 effectors were 
thought only important for the internalization of Salmonella; however recent of studies have 
revealed that many effectors of T3SS-1 have important roles in post-invasion processes that 
are discussed later in this chapter. 
3.2 SPI-2  
T3SS-2, encoded by SPI-2, is required for intracellular replication and immune evasion 
(Ochman et al., 1996; Shea et al., 1996; Waterman & Holden, 2003). Known effectors of T3SS-
2, encoded on SPI-2, include SpiC, SseF, SseG, whereas SifA, SifB, PipB, PipB2, SseI, SseJ, 
SseL, SspH2, GogB are other effectors of T3SS-2 which are encoded on a different loci 
(Lavigne & Blanc-Potard, 2008). To date, the effectors of T3SS-2 remain less understood than 
effectors of T3SS-1, although it is widely established that T3SS-2 is required for survival 
within host cells (Hensel et al., 1998). Several studies have also highlighted the importance 
of SPI-2 in systemic infection, while noting its contribution in intestinal disease and 
 
Salmonella – Distribution, Adaptation, Control Measures and Molecular Technologies 
 
316 
inflammation (Bispham et al., 2001; Coburn et al., 2005; Coombes et al., 2005; Hapfelmeier et 
al., 2005). T3SS-2 evasion processes are discussed in greater detail later in this chapter.  
3.3 SPI-3 
SPI-3 encodes virulence factors that are important in intestinal colonization and intracellular 
survival. MgtC is an inner membrane protein, common to several intracellular pathogens, 
required for intramacrophage survival (Alix & Blanc-Potard, 2007; Blanc-Potard & 
Groisman, 1997). SPI-2 also encodes MisL, a type V secretion system (T5SS) (Blanc-Potard et 
al., 1999; Henderson et al., 2004). Although not much is known about MisL, a recent study of 
S. Typhimurium demonstrates that MisL is important for intestinal colonization by 
promoting S. Typhimurium binding to fibronectin (Dorsey et al., 2005). 
3.4 SPI-4 
SPI-4 encodes a type I secretion system (T1SS) and also a substrate of T1SS, SiiE, a large 
(600kDa) surface-associated non-fimbrial adhensin that contributes to invasion and 
adhension to eukaryotic cells (Gerlach et al., 2007). Although encoded by SPI-4, SiiE is also 
coregulated by SPI-1. Little is known about the precise function of SPI-4, however a study in 
both calf and mouse models have revealed a role of SiiE in colonization and intestinal 
inflammation (Morgan et al., 2007).  
3.5 SPI-5  
Many additional effectors of T3SS-1, including SopA, SopB, SopD, SopE, SopE2, Ssph1 and 
Slrp, are not encoded on SPI-1; rather they are encoded by other horizontally acquired 
elements, such as on SPI-5 (Lavigne & Blanc-Potard, 2008; Wood et al., 1998). Some of these 
effectors, namely SopB and SopE/SopE2 induce dramatic rearrangement of the actin 
cytoskeleton in host cells, which results in large membrane ruffles and subsequent 
internalization of Salmonella (McGhie et al., 2009). 
3.6 SPI-7  
SPI-7 is a large 134 kb segment that encodes the Vi capsular polysaccharide antigen, Type IV 
pili and SopE (Hornick et al., 1970). The viaB locus is a 14Kb region within SPI-7 that 
prevents host recognition of Salmonella by TLR4 and TLR5 (Raffatellu et al., 2005). The locus 
contains genes that synthesize, regulate and export the Vi capsular antigen. The presence of 
the Vi antigen contributes greatly to the virulence in S. Typi, which is required for 
intracellular survival in phagocytes and has been implicated in system dissemination by 
virtue of its role in serum resistance (Hirose et al., 1997; Looney & Steigbigel, 1986). It should 
be noted that SPI-7 is expressed in S. Typhi and is absent in S. Typhimurium. 
3.7 Fimbriae & biofilm  
Four different types of fimbriae are known to be expressed by Salmonella that include type 1 
fimbriae, plasma-encoded fimbriae, long polar fimbriae and thin aggregrative fimbriae (curli), 
all of which seem to have specificities for different cell types (Darwin & Miller, 1999). A recent 
study has shown fimbriae, namely type 1 fimbrial adhesion FimH, mediates Salmonella uptake 
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into murine DCs in a T3SS-independent fashion (Guo et al., 2007). It is thought that 13 fimbrial 
loci exist in Salmonella, which are thought to aid the internalization process through biofilm 
formation, attachment to host cells and colonization (Humphries et al., 2001). Conversely, an 
earlier study has demonstrated a more invasive behavior of an S. Typhi mutant strain carrying 
a deletion of the fim genes (encoding type 1 fimbriae) compared to its wild-type strain (Miyake 
et al., 1998). It is thought that in the absence of type 1 fimbrial adhesions, various interactions 
between bacterial surface proteins and host cells may become more enhanced and result in a 
higher degree of invasion. BapA, a large cell-surface protein is also required for biofilm 
formation and subsequent evasion and colonization, similar to FimH (Latasa et al., 2005). 
BapA is secreted through T1SS (BapBCD) and its expression is orchestrated with genes 
encoding other fimbriae, suggesting important interplay in overall biofilm formation. The 
significance of the biofilm stems from the extreme environmental conditions the bacteria are 
subjected to, and their successful survival lies in their ability to grow in surface-attached 
biofilms protected by an extracellular matrix (Costerton et al., 1995; Davey & O'Toole G, 2000). 
The formation of biofilms, particularly in the gall bladder, contributes greatly to pathogenesis 
of chronically infected S. Typhi individuals. 
3.8 Flagella 
The role of flagella in Salmonellosis remains controversial due, in part, to seemingly 
conflicting studies and poorly understood intracellular mechanisms. For example, the 
evasiveness of Salmonella is increased via flagellar-based motility, despite the fact several 
studies have demonstrated that flagellin monomers are potent inducers of innate immunity 
(Franchi et al., 2006; Miao et al., 2006; Schmitt et al., 2001). Conversely, it has been well 
demonstrated that flagellin interacts with T3SS-1 from Salmonella-infected macrophages and 
is translocated into the cytosol resulting in activation of the inflammasome and subsequent 
cell death via caspase-1 pathway (discussed later in the chapter) (Miao et al., 2007; Ren et al., 
2006; Sun et al., 2007).  
4. Evasion of salmonella 
4.1 The Salmonella-containing vacuole (SCV) 
Following internalization, Salmonella becomes engrossed within a vacuole in which it is able 
to survive and replicate intracellularly. These vacuoles, termed Salmonella-containing 
vacuole (SCV) are characterised by the transformation of cell markers as the vacuole 
matures, displaying late endosome and lysosome markers, particularly lysosomes 
glycoprotein markers (Steele-Mortimer et al., 1999). Concurrent to marker transformation 
post-invasion, SCVs migrate from the periphery plasma membrane to a juxtanuclear 
position at the microtubule-organising centre (Deiwick et al., 2006; Salcedo & Holden, 2003). 
In some cell types, the onset of intracellular replication are marked by the presence of 
Salmonella-induced filaments (Sifs) which are branched membrane tubules expelling from 
the SCV (Drecktrah et al., 2008). Within the SCV, various processes occur, such as Salmonella 
transformation and immune modulation, which are imperative for survival, replication and 
dissemination of Salmonella. Following internalisation of Salmonella and translocation of SPI, 
SPI-effectors are localized to different cellular compartments, such as the Golgi apparatus 
and lysosomes (Freeman et al., 2003; Haraga & Miller, 2003; Knodler et al., 2003; Salcedo & 
Holden, 2003). The differential localisation pattern indicates the ability of SPI-effectors and 
thereby Salmonella to manipulate various aspects of host cell function. 
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4.2 Maturation and trafficking of SCV  
Initially, when SCV form, they are characterized by early endocytic markers, such as 
transferrin receptor (TfnR), early endosomal antigen 1 (EEA1) and several Rab GTPases, 
such as Rab4/5 & 11. In an effort to curb or delay lysosomal fusion, SCV deviates from the 
endocytic pathway, thereby reducing the likelihood of lysis of Salmonella. (Steele-Mortimer, 
2008). Maturing SCVs are characterised by replacement of earlier endocytic markers by later 
markers including Rab7, vacuolar ATPase (v-ATPase) and lysosomal membrane 
glycoproteins (1pgs), such as LAMP-1 (Steele-Mortimer, 2008).  
Several studies have implicated the effectors of T3SS-1, namely SopE and SopB in the 
maturation of SCV and replication of Salmonella within. SopE and SopB are required for the 
recruitment of Rab5 within the SCV, which binds the phosphatidylinositol 3-kinase (PI(3)P) 
Vps34 required for LAMP-1 recruitment (Mallo et al., 2008; Mukherjee et al., 2001; Steele-
Mortimer, 2008). Vps34 also acts via PI(3)P on the SCV membrane, which enables 
recruitment of EEA1(Mallo et al., 2008). SopB acts by inhibiting the degradation of 
epidermal growth factor receptor (EGFR) by lysosomes (Dukes et al., 2006). In a recent 
study, SopB has been attributed to the disappearance of late endosomal markers by 
recruiting sorting nexin-1 (SNX-1) which is speculated to down-regulate mannose 6-
phosphate receptor from maturing SCV (Bujny et al., 2008). Collectively, the current data 
pins a role for SopB in diverting SCV trafficking from the endosomal maturation pathway. 
In addition to this, SopB has also been demonstrated to indirectly increase intracellular 
Salmonella replication, via activation of Akt, which in turn deactivates Rab14 GAP, AS160 
(Layton & Galyov, 2007). The activated Rab14 increases intracellular Salmonella replication 
most likely by delaying SCV-lysosomal fusion (Kuijl et al., 2007). On the same note, SpiC, an 
effector of T3SS-2 is thought to prevent fusion of macrophage-late lysosomes with SCV 
(Steele-Mortimer, 2008).  
SseJ, another effector of T3SS-2 on the SPI-2, is localised to the SCVs and SIFs. A study in 
SseJ null mutant mice has revealed that SseJ is required for full virulence of Salmonella (Ruiz-
Albert et al., 2002). More specifically, an in vitro study has revealed deacylase activity of 
SseJ, while portraying its role in esterification of cholesterol, which is enriched in SCV 
(Brumell et al., 2001; Catron et al., 2002; Garner et al., 2002; Ohlson et al., 2005). It is thought 
the esterification of cholesterol could disrupt cell-signalling platforms or inhibit molecular 
interactions of complexes on the SCV, ultimately interfering with vesicular trafficking 
(Ohlson et al., 2005). 
SopA, an effector of SPI-1, promotes bacterial escape from the SCV in HeLa cells (Diao et al., 
2008). It is one of several effectors that is structurally and functionally similar to HECT E3 
ubiquitin ligases and is thought to have a role in disrupting SCV membrane integrity 
(Steele-Mortimer, 2008; Zhang et al., 2006).  
4.3 Sif biogenesis  
As mentioned previously, maturing SCVs migrate from the peripheral towards the 
perinuclear region of the host cell, strategically positioning themselves adjacent to the Golgi 
apparatus. This seems to be important for promoting bacterial replication and survival, and, 
as a recent study suggests, the close proximity of SCV to the Golgi apparatus may enable 
interception of endocytic and exocyclic transport vesicles to stockpile nutrients and/or 
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membrane materials (Ramsden et al., 2007). In line with this, exocytic transport vesicles are 
able to be averted from their normal path under the influence of SifA, SseG and SseF 
towards the SCV (Kuhle et al., 2006).  
In epithelial cells, SseG and SseF are required for the maintenance of SCV at the 
perinuclear region, while also appearing to be important for intracellular replication 
(Deiwick et al., 2006). SseG and Ssef are thought to either form ‘tethers’ from the SCV to 
the Golgi apparatus or manipulate dynein activity in an attempt to ‘glue’ the SCV to the 
microtubule-organising centre (MTOC) (Kuhle & Hensel, 2002; Ramsden et al., 2007; 
Salcedo & Holden, 2003). SopB is also required for the retention of the SCV within the 
perinuclear region by mediating the phosphorylation of actin-associated motor myosin II 
light chain (MLC) (Wasylnka et al., 2008).  
Once the SCV has positioned itself near the perinuclear region of the host cell, replication is 
initiated and is characterised by LAMP-rich specialised tubulovesicular structures called 
Salmonella-induced filaments (Sifs) that project from the SCV. The fusion of late endosome 
with the SCV is thought to induce Sif formation, however the precise role of Sifs remains 
elusive (McGhie et al., 2009; Steele-Mortimer, 2008). SifA is essential for the formation and 
maintenance of Sifs, by which SifA and two other T3SS-2 effectors, PibB2 and SseJ, cooperate 
to induce and drive extensions of Sif tubules from the juxtanuclear SCV towards the 
periphery of the host cell (Brumell et al., 2002; Henry et al., 2006; Knodler & Steele-
Mortimer, 2005). SifA is localised to the SCV by the TS33-1 effector SipA, where it forms a 
functional complex with the host protein SKIP (SifA and kinesin-interacting protein) (Brawn 
et al., 2007). SKIP has been shown to bind to the PibB2-induced microtubule-based motor 
kinesin-1 that drives Sif extensions (Boucrot et al., 2005; Brawn et al., 2007; Henry et al., 
2006). SKIP also directly interacts with various GTPases such as rab9 which is implicated in 
lysosome positioning and function, potentially displacing it from this complex (Barbero et 
al., 2002; Ganley et al., 2004; Jackson et al., 2008). In addition to this, SifA is also able to bind 
to rab7, uncoupling it from RILP and recruiting RhoA, another GTPase that promotes 
membrane tubulation when activated in the presence of SKIP and SseJ (Harrison et al., 2004; 
Lossi et al., 2008; Ohlson et al., 2008; Ramsden et al., 2007). Moreover, SseF and SseG are 
believed to augment Sif formation via modulation of aggregated endosomal compartments. 
In studies of Salmonella mutants lacking SseF and and SseG, SCVs induced fewer Sifs 
compared to wild type bacteria (Ramsden et al., 2007).  
Salmonella within the SCV have evolved mechanisms that allow it to escape the 
ubiquitination process by employing three T3SS-2 effectors that interfere with host 
ubiquitin pathways (Quezada et al., 2009). SseL is a deubiquitinase that acts via 
modulation of NF-KB, although the downstream effects are unclear (Coombes et al., 2007; 
Le Negrate et al., 2008; Rytkonen et al., 2007). SspH1 and SspH2 are both members of the 
ubiquitin E3 ligases family. More research is required to clearly define a role for these two 
effectors. Nevertheless a study has identified that SspH1 can ubiquitinate ubiquitin 
(Rohde et al., 2007).  
5. Surviving intracellularly 
Salmonella has successfully evolved several strategies to manipulate and supress cellular 
immune responses. SptP GAP and tyrosine phosphatase activities play critical roles in 
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reversing MAPK activation while AvrA acetyltransferase activity towards MAPK kinases 
inhibits Jnk activation (Jones et al., 2008; Lin et al., 2003; Murli et al., 2001). Moreover, SpvC 
has been shown to directly inhibit Erk, Jnk and p38 MAPKs via its phosphothreonine lyase 
activity (Li et al., 2007; Mazurkiewicz et al., 2008). 
The deubiquitinase activity of SPI-2 effector, SseL, is able to suppress NFκB activation by 
impairing IκBα ubiquitination and degradation (Le Negrate et al., 2008). This is thought to 
be an additional measure by which Salmonella is able to target transcription factors 
downstream from MAPK pathways to ensure immune suppression. AvrA also has a 
reportedly redundant role to SseL deubiquitinase activity and thereby acts in a similar 
manner (Ye et al., 2007). Furthermore, SspH1 inhibits NFkB-dependant gene expression, 
although the precise mechanisms are unclear (Rohde et al., 2007). The production of reactive 
host species by many host cells is imperative for killing intracellular pathogens. This is 
essentially through the employment of NADPH oxidase (NOX2) activity found in 
lysosomes. Salmonella is able to evade this activity by utilizing SodCl, a superoxide 
dismutase, which protects itself from the reactive oxygen species.  
Metal availability in host eukaryotic cells is required for full virulence of Salmonella. Of 
many trace elements reportedly utilised by Salmonella, iron appears most important. Iron is a 
cofactor for various fundamental enzymes and metabolic processes in Salmonella, which 
must compete with the host cell to obtain this ion (Schaible & Kaufmann, 2004). 
Epidemiological evidence from patients with β-thalassaemia has demonstrated an increased 
susceptibility of Salmonella infection (Wanachiwanawin, 2000). Similarly, Salmonella 
virulence was exacerbated in laboratory conditions replicating iron overload (Sawatzki et 
al., 1983). Further evidence of increased virulence of Salmonella in iron favouring conditions 
stems from the attenuated intracellular growth of mutant S. Typhi whose iron uptake 
abilities are impaired (Furman et al., 1994). 
In light of the importance of iron in Salmonella virulence, it is not surprising that Salmonella 
has evolved strategies in acquiring various metals for intracellular survival. The iron 
availability in eukaryotic hosts is limited due to activity of transferrin and natural 
resistance-associated macrophage protein one (Nramp1) (Nairz et al., 2009). Additionally, 
during bouts of inflammation, the antimicrobial protein lipocalin-2 further inhibits bacterial 
iron acquisition, creating an environment highly unfavourable for Salmonella and other 
intracellular bacteria (Raffatellu et al., 2009). Salmonella therefore employs two siderophores, 
enterobactin and salmonchelin, when acquiring iron in highly competitive conditions 
(Muller et al., 2009). Salmonechelin, a glucoslyated derivative of enterobactin, is thought to 
resist or inhibit lipocalin-2 function (Raffatellu et al., 2009). Furthermore, SCVs in 
macrophages contain enough iron to affect activity of metal-responsive promoters, 
independently of Nramp1 (Taylor et al., 2009).  
Magnesium is also significant for intracellular survival of Salmonella and is delivered by three 
distinct systems for uptake: CorA, MgtA and MgtB (Blanc-Potard & Groisman, 1997). Zinc and 
potassium are also implicated in intracellular survival of Salmonella. In low zinc conditions, 
ZnuABC Zn2+ uptake system demonstrates its importance intracellularly, while further studies 
with ZnuABC mutants have supported the importance of zinc acquisition for virulence of 
Salmonella (Ammendola et al., 2007). Finally, the Trk complex system functions as a low-
affinity K+ transporter and resist host antimicrobial peptides(Parra-Lopez et al., 1994). 
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6. Effector modulation of host immunity  
Many SPI effectors can induce symptoms that are the hallmark feature of salmonellosis, 
such as acute intestinal inflammation and diarrhoea, through activation of immune cells and 
release of cytokines. During Salmonella invasion, transcription factors AP-1 and NFκB are 
activated via stimulation of Cdc42 by SPI-1 effectors SopE/SopE2 and SopB. More 
specifically, Erk, Jnk and p38 mitogen-activated protein kinase (MAPK) are unregulated in a 
Raf1-dependant fashion that ultimately result in transcription of AP-1 and NFκB to release 
proinflammatory cytokines such as IL-8, recruiting polymorphonuclear leukocytes (PMNs) 
(Layton & Galyov, 2007; Patel & Galan, 2006, 2005). Concomitantly, SipA triggers the Arf6- 
and phospholipase D signalling cascade, releasing PMN chemoattractant hepoxillin A3 
apically via protein kinase Cα (Layton & Galyov, 2007; Wall et al., 2007). As a result, PMN 
chemoattractant hepoxillin A3 promotes transmigration of PMN across the epithelium into 
the intestinal lumen. The actions of SopB, SopE, SopE2 and SipA are likely to disturb the 
integrity in the epithelial barrier and result further in PMN transmigration whilst promoting 
fluid flux, thereby contributing to diarrhoea (Boyle et al., 2006). SopB is also known to play a 
role in the induction of diarrhoea due to its inositol phosphatase activity, producing 
Ins(1,4,5,6)P4, which promotes cellular chloride ion secetion and fluid flux (Layton & 
Galyov, 2007). Contrary to this, the SPI-1 effector, AvrA,, has been shown to have 
countering effects on ion secretion by stabilising cell permeability and tight junctions in 
intestinal epithelial cells (Liao et al., 2008). This action is believed to have a strategic 
advantage to bacterial survival since disruption of the epithelial lining also increases the 
inflammatory response. Therefore AvrA may help Salmonella survive in the host during by 
dampening intestinal inflammation.  
7. Cell death 
‘From death comes life’ A proverb that seems to rings true during Salmonella infection of 
host cells. The relationship between Salmonella invasion and cell death has been long 
implicated; however the once simplistic model has now evolved to include many different 
mechanisms in which Salmonella prompts cell death. 
In many ways the epithelium provides a barrier, both physical and chemical, that 
demarcates two environments whilst selectively allowing particles to migrate to their new 
world. The internalization of Salmonella alone, mostly by epithelial lining cells, does not 
guarantee access to the underlying tissue. Rather, the phenomenon of cell death is thought 
to create the perfect opportunity for Salmonella to reach and infect Peyer's patches and 
disseminate to systemic tissues in the host. Internalized Salmonella in cultured epithelial cells 
is able to exploit and induce apoptosis in vitro after 8-12 hours, in a manner that is 
characteristic of apoptosis, such as activation of apoptotic caspase-3 and caspase-8 (Kim et 
al., 1998; Paesold et al., 2002; Zeng et al., 2006). Apoptosis is best defined as an active, 
controlled, genetically regulated and ATP-requiring process that results in cell death in the 
face of aging or damaged cells (Danial & Korsmeyer, 2004; Kerr et al., 1972). The bacterial 
invasion and synthesis of bacterial proteins from SPI-2 T3SS-II and spv genes are required 
for intracellular proliferation and induction of apoptosis (Paesold et al., 2002). Additionally, 
following bacterial invasion, host cellular production of inflammatory mediators, such as 
TNF-α and nitric oxide, are all thought to contribute to epithelial cell apoptosis. It should be 
noted that apoptosis of Salmonella-infested epithelial cells is a relatively delayed event, 
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which is thought to favour intracellular reproduction, increasing the overall niche of 
intracellular Salmonella (Kim et al., 1998).  
A relatively newly defined form of apoptosis utilized by Salmonella and other intracellular 
residing bacteria is termed pyroptosis. Its unique mechanism, features and inflammatory 
outcome distinguishes it from our current understanding of apoptosis (Fink & Cookson, 
2007; Hersh et al., 1999). Pyroptosis is caspase-1 dependant which is activated in the 
inflammasome during Salmonella infection. This differs from apoptosis in that caspase-3 and 
not caspase-1 is central to cell death (Brennan & Cookson, 2000; Jesenberger et al., 2000). 
Additionally, Caspase-3 is not activated in pyroptosis, nor is caspase-6 and caspase-8. 
Furthermore, the characteristic mitochondrial release of cytochrome c in apoptosis does not 
occur during pyroptosis (Jesenberger et al., 2000). Finally, the unique inflammatory outcome 
of pyroptosis stems from caspase-1 ability to release proinflammatory cytokines IL-1β and 
IL-18 by cleaving their precursor molecules (Fantuzzi & Dinarello, 1999).  
The SPI-1 effector, SipB has been heavily implicated in host cell death of following 
Salmonella internalization of macrophages, as supported by a study which showed reduced 
apoptosis following infection of SPI-1 mutant Salmonella (Monack et al., 2004). SipB is able to 
bind and activate caspase-1, triggering rapid pyroptosis. Flagellin is also demonstrated to be 
necessary in caspase-1-mediated, SPI-1-dependent pyroptosis, as observed in flagellin void 
Salmonella mutants (Franchi et al., 2006; Miao et al., 2006). It should be noted that pyroptosis 
is not limited in macrophages, as caspase-1-dependant death has also been observed in 
Salmonella-infected DCs (van der Velden et al., 2003). Another described pyroptosis in 
Salmonella infected macrophages, dubbed ‘Delayed SPI-2-dependant caspase-1-mediated 
pyroptosis, is thought to be important during the systemic phase of infection, as SPI-1 
effectors and flagellin are both repressed during this stage (Cummings et al., 2005; Fink & 
Cookson, 2007; Schlumberger & Hardt, 2006). Delayed macrophage death also requires 
expression of the spvB gene, as mutations in this gene prevent induction of delayed 
macrophage death (Browne et al., 2002; Libby et al., 2000). Despite this, Spv genes may not 
directly affect cytotoxicity as Spv mutants show attenuated intracellular replication and 
therefore may indirectly affect cytotoxicity through intracellular proliferation of Salmonella 
(Fink & Cookson, 2007). Delayed macrophage pyroptosis may heavily contribute to 
virulence of Salmonella, as dissemination is largely through Salmonella-infected macrophages 
(Fields et al., 1986). Therefore, delaying cell death and the subsequent release of Salmonella 
will allow the bacterium to disseminate further virtually undetected. Finally, an extremely 
late event of apoptosis in Salmonella-infected macrophages has been observed in caspase-1-
deficient macrophages, which is caspase-1-indepedant (Hernandez et al., 2003; Jesenberger 
et al., 2000). SPI-1 and more notably, sipB, are shown to be required for this caspase-1-
indepenant apoptosis in macrophages (Hernandez et al., 2003; Jesenberger et al., 2000). This 
process acts via the release of mitochondrial cytochrome c and activation of caspase-2, 
caspase-3, caspase-6 and caspase-8, resulting in apoptosis (Jesenberger et al., 2000). More 
research is required to clarify the role of caspase-1-independent apoptosis in the 
physiological setting of Salmonellosis. 
The many failsafe’s of Salmonella mediated cell death has caused greater debate on the 
effects in the virulence of Salmonella. In light of the fact that pyroptosis produces an 
inflammatory outcome, one may speculate that this pathway may have important 
implications in host protection. Contrarily, epithelial cell death via apoptosis is believed to 
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enhance bacterial migration and dissemination as this would likely result in a breach of the 
epithelial barrier and thereby allow more Salmonella to pass into underlying tissue. Further 
research in Salmonella mediated cell death may help clarify this seemly paradoxical event.  
8. Serum resistance  
Serum resistance and subsequent typhoid fever is a characteristic phenomenon observed in 
cases of S. Typhi infection. Unlike S. Typhimurium, S. Typhi is host specific and it does not 
persist in animals and thus is inherently difficult to study in vivo conditions. As a result, 
volunteer studies have been essential in establishing the pathogenesis of typhoid fever. 
Following mucosa invasion of S. Typhimurium, host pattern recognition receptors recognise 
various pathogen-associated molecular patterns (PAMPs) that are unique to bacteria. Such 
receptors include Toll-like receptor 4 (TLR-4) which recognises lipopolysaccharide (LPS) 
and TLR-5 that is exclusively expressed on the basolateral surface of epithelial cells which 
recognises and binds flagellin (Gewirtz et al., 2001; Hayashi et al., 2001; Poltorak et al., 1998). 
Activation of TLR signalling induces expression of various proinflammatory cytokines such 
as TNF-α and chemokine IL-8, recruiting neutrophils to the intestinal mucosa. These 
inflammatory markers are essential to the containment and clearance of Salmonella 
infection in the mucosa (Raffatellu et al., 2006). Contrasting this, S. Typhi invasion of the 
intestinal mucosa does not initiate effective immune response, nor triggers the neutrophil 
influx that is characteristic of S. Typhimurium. This is due to the expression of the Vi 
capsular antigen on the SPI-7 that is absent in S. Typhimurium. The expression of the Vi 
capsular antigen in S. Typhi is thought to down-regulate the TLR-mediated host response 
in the intestinal mucosa, ultimately allowing bacteria to escape the immune defence line 
and disseminate to the liver, bone marrow and gall bladder (Tsolis et al., 2008). In human 
colonic epithelial cell lines, capsulated S. Typhi reduces IL-8 production, while in a similar 
study, noncapsulated S. Typhi triggers more IL-8 and TNF-alpha production (Hirose et 
al., 1997; Raffatellu et al., 2005; Sharma & Qadri, 2004). Capsulated S. Typhi interferes 
with TLR5 and TLR4/MD2/CD14 stimulation by flagella and LPS, respectively (Miyake 
et al., 1998). In this view, the Vi capsular antigen appears to deafen the immune system by 
simply reducing immunological stimulation and subsequent response. An earlier study 
has revealed an approximate 10,000-fold decrease in the virulence of non-capsulated S. 
Typhi in an intraperitoneal mouse model of infection (Hone et al., 1988). Similarly, a 
volunteer study has demonstrated a significant increase in disease activity amongst those 
infected with capsulated S. Typhi (Hornick et al., 1970). Finally, vaccination with the Vi 
antigen has confirmed protection during human infection with capsulated S. Typhi 
(Klugman et al., 1987).  
Numerous theories by which the Vi capsular antigen inhibits inflammation have been 
proposed, two of which are most widely accepted. Primarily, Vi capsular antigen may 
physically mask PAMPs, thereby interfering with TLR stimulation (Raffatellu et al., 2006). 
This is supported by studies which found that the Vi antigen blocks the agglutination of S. 
Typhi with anti-LPS serum (Felix, 1934). Vi antigen also inhibits type 1 fimbriae mediated 
agglutination in Saccharomyces cerevisiae, collectively insinuating that the capsule physically 
masks surface structures (Miyake et al., 1998). Secondly, it has been suggested that the Vi 
antigen may attenuate downstream signalling related to IL-8 production (Qadri, 1997; 
Sharma & Qadri, 2004). Despite its early discovery, many questions regarding Vi capsular 
antigen mechanisms remain unanswered. This is due to the limitations of directly studying 
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the Vi capsular antigen in vivo in laboratory condition. Vi antigen expression is markedly 
reduced, if not obliterated, when transferred to the laboratory. This characteristic loss of the 
Vi capsular antigen is ascribed to the genetic instability of the SPI-7, which frequently is lost 
in the laboratory passage (Bueno et al., 2004). 
S. Typhi blood isolates from infected patients suggests that Vi antigen expression is 
invariable (Robbins & Robbins, 1984). However, S. Typhi isolates in human stool samples 
revealed a lack of Vi capsular antigen expression, compared to blood samples in the same 
patients (James Craigie, 1936). Moreover, recent in vitro studies have suggested that S. Typhi 
downregulates the expression of the Vi capsular antigen in the intestinal lumen as a result of 
the inherent high osmolarity of the region (Pickard et al., 1994). Concurrently, flagella 
expression is unregulated, while T3SS-1 genes are expressed (Arricau et al., 1998). These 
studies have revealed the transient nature of Vi expression during various stages of S. Typhi 
infection. The environmental shift between the high osmolarity of the intestinal lumen and 
low osmolarity inside the host tissue appears to promote expression of the Vi capsular 
antigen, while simultaneously repressing mobility and invasiveness. Upon invasion into the 
underlying epithelium, S. Typhi encounters low osmolarity within its new environment, 
thus triggering two component regulatory systems RcsBC and OmpR EnvZ. Both 
components activate Vi antigen expression while the expression of flagella and T3SS-1 genes 
are reduced (Arricau et al., 1998; Pickard et al., 1994; Virlogeux et al., 1996). The effects of Vi 
antigen expression on S. Typhi virulence are demonstrated in recent in vitro studies in which 
capsulated S. Typhi is resistant to phagocytosis (Looney & Steigbigel, 1986). These findings 
perplex the role virulent T3SS-1 effectors in intracellular survival of macrophages. 
9. Typhoid fever or septic shock? 
Unlike S. Typhi, S. Typhimurium and other non-typhoidal Salmonella serotypes generally do 
not elicit typhoid fever due to the absence of the SPI-7 and therefore Vi capsular antigen. In 
immunocompetent individuals, non-typhoidal Salmonella serotypes prompt a strong 
immune response, marked by neutrophil influx and inflammatory diarrhoea which help 
contain the infection in the intestinal mucosa. Conversely, immunocompromised patients 
infected with non-typhoidal Salmonella serotypes develop fulminant bacteraemia, a clinical 
presentation markedly different to that of typhoid fever (Tsolis et al., 2008). The failed 
containment of non-typhoidal Salmonella to the intestinal mucous leads to bacterial 
dissemination to the blood stream, prompting an aggressive immune response towards 
bacteria associated LPS. LPS, a known inducer of endotoxic shock, binds the TLR4-MD-2-
CD14 receptor complex inducing an excessive inflammatory response marked by release of 
TNF-α, IFN-γ and IL-1β (Hoebe et al., 2004). Endotoxic shock is characterised by a decrease 
in hypotension and microvascular thrombosis as the result of fibrin deposition in capillaries 
(Waage et al., 1991). LPS is thought to contribute to septic shock and mortality in patients 
with non-typhoidal Salmonella, in part due to the rapid production of TLR4-dependant TNF-
α in macrophages (Engelberts et al., 1991; Wilson et al., 2008). The synergic induction of 
nitric oxide synthase, by TNF-α, IFN-γ and IL-1β, increases production of nitric oxide which 
is a powerful vasodilator contributing to hypotension (Petros et al., 1991). In addition to this, 
TNF-α increases tissue-factor expression on monocytes, resulting in cleavage of serum 
fibrinogen to fibrin (Carlsen et al., 1988). Deposits of fibrin in microvasculature lead to 
intravascular coagulopathy, which can cause organ failure (Waage et al., 1991). Contrary to 
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the robust immunological response to non-typhoidal Salmonella serotypes, S. Typhi induces 
only a weak immune response. This is paralleled in the clinical setting as coagulatory 
abnormalities are not apparent in patients with typhoid fever (Butler et al., 1978). 
Furthermore, serum cytokine levels in patients with typhoid fever were relatively lower 
when compared to patients with gram-negative septic shock (Raffatellu et al., 2006). The 
impaired identification and host response towards S. Typhi is attributed to its ability to 
conceal two important molecular signatures, LPS and flagellin. As mentioned previously, 
the Vi capsular antigen is thought to mask the physical structure of LPS, thereby evading 
TLR4 recognition and subsequent response. Additionally, viaB locus in SPI-7 is also able to 
attenuate TLR5 signalling, albeit via a different mechanism. TviA, a regulatory protein 
encoded by the viaB, suppresses the transcription of locus flhC and flhD, both of which 
encode the master regulator of flagella expression (Winter et al., 2008). As a result, the 
transcription of the flagellin gene fliC is reduced and therefore flagellin is downregulated. 
This unique mechanism allows S. Typhi to evade TLR5 recognition of flagellin.  
10. Persistence 
The vast majority of patients with acute typhoid fever recover following adequate 
treatment; however 3-5% of cases develop a chronic infection in the gall bladder (Levine et 
al., 1982; Merselis et al., 1964). In light of the fact that S. Typhi is a human restrictive 
pathogen, these chronically affected individuals form crucial reservoirs for future spread via 
the faecal and urinal oral route (Bhan et al., 2005; Khatri et al., 2009). Furthermore, 
chronically affected individuals are almost always asymptomic, making identification of 
possible carriers a difficult task (Shpargel et al., 1985; Sinnott & Teall, 1987).  
Epidemiological studies have revealed a strong association between chronic carriers of S. 
Typhi and gallstones (Schioler et al., 1983). Moreover, 90% of chronically affected 
individuals have gallstones (Karaki & Matsubara, 1984). Alongside S. Typhi, many other 
bacterium have been implicated in the development of gallstones and later cholecystitis, an 
inflammation and obstruction of the gallbladder (Capoor et al., 2008; Swidsinski & Lee, 
2001). Despite much research, it remains unclear whether S. Typhi and other bacterium 
directly cause cholecystitis, or rather colonise previously damaged gall bladders (Cohen et 
al., 1987; Vaishnavi et al., 2005; Vogelsang & Boe, 1948). 
Being the site of bile storage, the gall bladder possesses a harsh environment and therefore 
can only be inhabited by organisms resistant to the bile (van Velkinburgh & Gunn, 1999) 
(Thanassi et al., 1997). S. Typhi is known to form biofilms in abiotic and biotic surfaces and it 
is therefore not surprising that S. Typhi forms biofilms in the gall bladder (Ledeboer & 
Jones, 2005). Interestingly, however, formation of Salmonella biofilms on gallstones is 
dependent on the presence of bile (Prouty et al., 2002). Bile is known to interact and 
manipulate gene expression in Salmonella biofilms, such as downregulating SPI-1 genes and 
mobility genes (Crawford et al., 2010; Prouty & Gunn, 2000). Despite this, the effects are 
believed to be minimal and may not dramatically affect the abilitiy of Salmonella’s to invade 
via effectors of SPI-1 or migrate via flagella. As S. Typhi is a human-restricted pathogen, 
utilising laboratory models such as S. Typhimurium does not truly mimic the pathogenesis 
of typhoid fever as S. Typhimurium induces a characteristic neutrophil response that is 
otherwise absent in S. Typhi. Therefore, much of our current understanding of S. Typhi 
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resistance in gall bladders stems from in vitro biofilm models, such as tube biofilm assays 
(TBA)(Gonzalez-Escobedo et al., 2011). Earlier studies have established the essential role of 
biofilm formation on gallstones removed from patients chronically infected with S. Typhi 
(Prouty et al., 2002). More recently, TBAs have revealed the bile-dependant enhancement of 
S. Typhi biofilms and specific binding to cholesterol-coated surfaces, such as in some cases 
of gallstones (Crawford et al., 2008). Furthermore, TBA’s have also confirmed that the 
flagellin subunit fliCI is necessary for initial binding to cholesterol-coated surfaces. In 
addition to this, outer-membrance protein C (OmpC) also affects binding of S. Typhi 
biofilms to cholesterol (Crawford et al., 2010). Following the initial attachment phase, 
formation of microcolonies typically precedes the development to mature biofilm. During 
these two latter stages, extracellular polymeric substances (EPS) help biofilm structural 
development and cell-cell interaction (Costerton et al., 1999). In S. Typhi infected 
gallbladders, EPS is primarily composed of cellulose, colanic acid, Vi capsular antigen, curli 
fimbriae, O antigen capsule and biofilm associated proteins (Gibson et al., 2006; Gonzalez-
Escobedo et al., 2011; Jonas et al., 2007; Ledeboer & Jones, 2005). Although the role of some 
elements in the EPS remain minor, other elements such as cellulose, colonic acid and O 
antigen capsule are crucial for S. Typhi persistence and biofilm development (Crawford et 
al., 2008; Prouty & Gunn, 2003; Prouty et al., 2002).  
Biofilm development is an important component of bacterial survival and persistence. In 
order to decipher the complex interaction between S. Typhi biofilm and gallbladder further 
research is required. Humanised moue models are currently in development and may 
provide useful data by allowing S. Typhi to be studied directly in biofilm formation and 
gallbladder persistence (Song et al., 2010).  
11. Conclusion 
In the last two decades, incredible progress has been made in our understanding of the very 
complex host-Salmonella interactions. Furthermore, current therapeutic developments reflect 
our current knowledge of molecular events during Salmonellosis. Despite this, existing 
animal models used to decipher Salmonella and host interactions have severe limitations and 
implications in the clinical scenario. For example, the scarcity of data on S. Typhi, due to no 
suitable animal models available, has limited our understanding and therefore therapeutic 
development in human typhoid. Although the recently developed streptomycin pre-treated 
murine model has greatly enhanced our understanding of S. Typhimurium, we must 
caution ourselves in over interpreting data as S. Typhimurium mouse model does not 
always reflect the human disease. Until laboratory based in vivo models of S. Typhi are 
established, scientists must rely on a combination of existing models to help increase our 
understanding of the infectious processes.  
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